Compass Therapeutics (CMPX) Earnings Date, Estimates & Call Transcripts $2.78 -0.13 (-4.47%) Closing price 08/7/2025 04:00 PM EasternExtended Trading$2.83 +0.05 (+1.65%) As of 08/7/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Compass Therapeutics Earnings Summary Compass Therapeutics announced Q1 2025 earnings on May 8, 2025, reporting an EPS of -$0.12, which hit analysts' consensus estimates of -$0.12. With a trailing EPS of -$0.41, Compass Therapeutics' earnings are expected to decrease next year, from ($0.36) to ($0.44) per share. Upcoming Q2 Earnings DateAug. 11EstimatedConsensus EPS (May. 8) -$0.12 Actual EPS (May. 8) -$0.12 Q1 2025 Earnings ResourcesQ1 2025 Earnings Report Quarterly Report (10-Q) Press Release (8-K)CMPX Upcoming EarningsCompass Therapeutics' Q2 2025 earnings is scheduled for Monday, August 11, 2025, with a conference call scheduled at 8:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q2 2025 Earnings ReportPowered by Get Compass Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Compass Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataCMPX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Compass Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20253-$0.15-$0.07-$0.11Q2 20253-$0.17-$0.08-$0.13Q3 20253-$0.18-$0.13-$0.15Q4 20253-$0.16-$0.07-$0.12 Compass Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/11/2025(Estimated)-------5/8/2025Q1 2025-$0.12-$0.12--$0.12--2/27/2025Q4 2024-$0.10-$0.11 -$0.01-$0.11--11/12/2024--$0.11-$0.08+$0.03-$0.08--8/12/2024--$0.10-$0.10--$0.10-$0.85M5/13/2024Q1 2024-$0.11-$0.08+$0.03-$0.08--3/21/2024Q4 2023-$0.09-$0.11 -$0.02-$0.11--11/9/2023Q3 2023-$0.11-$0.08+$0.03-$0.08-- Compass Therapeutics Earnings - Frequently Asked Questions When is Compass Therapeutics' earnings date? Compass Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 11th, 2025 based off last year's report dates. Learn more on CMPX's earnings history. Did Compass Therapeutics beat their earnings estimates last quarter? In the previous quarter, Compass Therapeutics (NASDAQ:CMPX) reported ($0.12) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.12). Learn more on analysts' earnings estimate vs. CMPX's actual earnings. How much revenue does Compass Therapeutics generate each year? Compass Therapeutics (NASDAQ:CMPX) has a recorded annual revenue of $850,000.00. How much profit does Compass Therapeutics generate each year? Compass Therapeutics (NASDAQ:CMPX) has a recorded net income of -$49.38 million. CMPX has generated -$0.41 earnings per share over the last four quarters. What is Compass Therapeutics' EPS forecast for next year? Compass Therapeutics' earnings are expected to decrease from ($0.36) per share to ($0.44) per share in the next year. More Earnings Resources from MarketBeat Related Companies Adaptive Biotechnologies Earnings Date Sarepta Therapeutics Earnings Date Edgewise Therapeutics Earnings Date Biohaven Earnings Date Schrodinger Earnings Date Dyne Therapeutics Earnings Date Janux Therapeutics Earnings Date Travere Therapeutics Earnings Date ANI Pharmaceuticals Earnings Date Aurinia Pharmaceuticals Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Constellation Energy’s Earnings Beat Signals a New EraRealty Income Rallies Post-Earnings Miss—Here’s What Drove ItDon't Mix the Signal for Noise in Super Micro Computer's EarningsWhy Monolithic Power's Earnings and Guidance Ignited a RallyRivian Takes Earnings Hit—R2 Could Be the Stock's 2026 LifelinePalantir Stock Soars After Blowout Earnings ReportVertical Aerospace's New Deal and Earnings De-Risk Production This page (NASDAQ:CMPX) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Compass Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Compass Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CMPX Stock Alerts